Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 3Withdrawn 2Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 2Gastroesophageal Reflux 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 213Irinotecan 146Leucovorin 140Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Bevacizumab 99Drug Therapy 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Gastroenterostomy × Gastrointestinal × Clear all
NCT02936193 2019-11-05

LAPPG

RenJi Hospital

Phase NA Unknown
100 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02572050 2016-04-20

AaRon

National Cancer Center, Korea

Phase 2 Unknown
87 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01142271 2011-11-07

Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy

Ajou University School of Medicine

Phase 3 Unknown
120 enrolled
Gastrointestinal

Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡